Validation of the modified Microlife blood pressure monitor in patients with paroxysmal atrial fibrillation

AIMS: Undiagnosed atrial fibrillation (AF) accounts for 6% of all strokes, therefore early detection and treatment of the arrhythmia are paramount. Previous research has illustrated that the Microlife WatchBPO3 AFIB, an automated blood pressure (BP) monitor with an inbuilt AF algorithm, accurately d...

Descripción completa

Detalles Bibliográficos
Autores principales: Huppertz, Nina, Lip, Gregory Y. H., Lane, Deirdre A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308245/
https://www.ncbi.nlm.nih.gov/pubmed/31701215
http://dx.doi.org/10.1007/s00392-019-01567-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308245/
https://www.ncbi.nlm.nih.gov/pubmed/31701215
http://dx.doi.org/10.1007/s00392-019-01567-y

Ejemplares similares